These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23010891)

  • 1. Participation of protein kinase C in the activation of Nrf2 signaling by ischemic preconditioning in the isolated rabbit heart.
    Zhang X; Xiao Z; Yao J; Zhao G; Fa X; Niu J
    Mol Cell Biochem; 2013 Jan; 372(1-2):169-79. PubMed ID: 23010891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of protein kinase C delta reduces hepatocellular damage in ischemic preconditioned rat liver.
    Yun N; Lee SM
    J Surg Res; 2013 Dec; 185(2):869-76. PubMed ID: 23932656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+ as a mediator of ischemic preconditioning.
    Miyawaki H; Ashraf M
    Circ Res; 1997 Jun; 80(6):790-9. PubMed ID: 9168781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effect of protein kinase C on heart function: an experiment with isolated rabbit hearts].
    Zhang X; Chen RK; Niu JL
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1122-4. PubMed ID: 16796840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential consequences of protein kinase C activation during early and late hepatic ischemic preconditioning.
    Yun N; Kim SH; Lee SM
    J Physiol Sci; 2012 May; 62(3):199-209. PubMed ID: 22359070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of dopamine D2 receptors activation in ischemic post-conditioning-induced cardioprotection through promoting PKC-ε particulate translocation in isolated rat hearts.
    Gao J; Guo J; Li H; Bai S; Li H; Wu B; Wang L; Xi Y; Tian Y; Yang G; Wang R; Wu L; Xu C; Li H
    Mol Cell Biochem; 2013 Jul; 379(1-2):267-76. PubMed ID: 23636617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning.
    Hattori R; Otani H; Uchiyama T; Imamura H; Cui J; Maulik N; Cordis GA; Zhu L; Das DK
    Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H1066-74. PubMed ID: 11514272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
    Nuñez RE; Javadov S; Escobales N
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of protein kinase C between ischemic and pharmacological preconditioning in the rabbit heart.
    Okubo S; Tanabe Y; Fujioka N; Takeda K; Takekoshi N
    Jpn J Physiol; 2003 Jun; 53(3):173-80. PubMed ID: 14529578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits.
    Ping P; Zhang J; Cao X; Li RC; Kong D; Tang XL; Qiu Y; Manchikalapudi S; Auchampach JA; Black RG; Bolli R
    Am J Physiol; 1999 May; 276(5):H1468-81. PubMed ID: 10330229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Rohilla A; Singh G; Singh M; Bala kumar P
    Biomed Pharmacother; 2010 Mar; 64(3):195-202. PubMed ID: 19914792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infarct size-limiting effect of calcium preconditioning in rabbit hearts.
    Kim HD
    J Korean Med Sci; 2003 Jun; 18(3):337-43. PubMed ID: 12808318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opening of mitochondrial K(ATP) channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioning.
    Ohnuma Y; Miura T; Miki T; Tanno M; Kuno A; Tsuchida A; Shimamoto K
    Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H440-7. PubMed ID: 12063319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium.
    Hassouna A; Matata BM; Galiñanes M
    Am J Physiol Cell Physiol; 2004 Nov; 287(5):C1418-25. PubMed ID: 15294852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The divergent roles of protein kinase C epsilon and delta in simulated ischaemia-reperfusion injury in human myocardium.
    Sivaraman V; Hausenloy DJ; Kolvekar S; Hayward M; Yap J; Lawrence D; Di Salvo C; Yellon DM
    J Mol Cell Cardiol; 2009 May; 46(5):758-64. PubMed ID: 19248786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity.
    Ping P; Zhang J; Qiu Y; Tang XL; Manchikalapudi S; Cao X; Bolli R
    Circ Res; 1997 Sep; 81(3):404-14. PubMed ID: 9285643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of protein kinase C in mitochondrial KATP channel-mediated protection against Ca2+ overload injury in rat myocardium.
    Wang Y; Ashraf M
    Circ Res; 1999 May; 84(10):1156-65. PubMed ID: 10347090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C-epsilon is a trigger of delayed cardioprotection against myocardial ischemia of kappa-opioid receptor stimulation in rat ventricular myocytes.
    Wang GY; Zhou JJ; Shan J; Wong TM
    J Pharmacol Exp Ther; 2001 Nov; 299(2):603-10. PubMed ID: 11602672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart.
    Lange SA; Wolf B; Schober K; Wunderlich C; Marquetant R; Weinbrenner C; Strasser RH
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):46-55. PubMed ID: 17261963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.